CD274 and neoplasm: The limitations of these studies include small patient cohorts, use of different assays to detect PD-L1, a lack of clear cut-offs for defining PD-L1 positivity on CTCs, and the inability to demonstrate concordance between PD-L1 expression on CTCs and tumour biopsy tissue.